Market Cap (In CNY)
4.13 Billion
Revenue (In CNY)
2.19 Billion
Net Income (In CNY)
44.35 Million
Avg. Volume
10.94 Million
- Currency
- CNY
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 4.04-7.38
- PE
- 28.18
- EPS
- 0.22
- Beta Value
- 0.329
- ISIN
- CNE0000008M0
- CUSIP
- -
- CIK
- -
- Shares
- 595987000.0
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Mr. Ping Dong Yuan
- Employee Count
- -
- Website
- https://www.pku-hc.com
- Ipo Date
- 1997-06-16
- Details
- PKU HealthCare Corp.,Ltd. researches, develops, manufactures, and sells pharmaceutical products in China. It offers products in various categories, including anti-tumor, neuropsychiatric, cardiovascular, immunosuppressive, antimicrobial, antipyretic and analgesic, digestive system, regulate immunity, oncology, anti-allergic, blood sugar regulation, mental disorder, and blood volume expansion. The company was formerly known as PUK International Hospital Group Southwest Synthetic Pharmaceutical Corp., Ltd. and changed its name to PKU HealthCare Corp., Ltd. in November 2013. PKU HealthCare Corp.,Ltd. was founded in 1965 and is headquartered in Chongqing, China.
More Stocks
-
CGL
-
301006Meter Instruments Co., Ltd.
301006
-
1770
-
AHCHF
-
SUDARSHANSUDARSHAN PHARMA INDUSTRIES LI
SUDARSHAN
-
LRCDF
-
300686
-
AREXMISArex Industries Limited
AREXMIS